Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection

Medical Mycology

Volumn 51, Issue 3, 2013, Pages 319-323

  Thompson III, George R ^a   Bays, Derek ^a   Taylor, Sandra L ^a   Cohen, Stuart H ^a   Pappagianis, Demosthenes ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

25(OH) vitamin D; Coccidioidomycosis; Fungal; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTICLE; CLINICAL ARTICLE; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENINGITIS; PNEUMONIA; VITAMIN D DEFICIENCY;

EID: 84875179704     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.690536     Document Type: Article

References (22)

1. Fabri M, Stenger S, Shin DM, et al. Vitamin D is required for IFNgamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011; 3: 1 - 10.
2. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense. J Immunol 2008; 181: 7090 - 7099.
3. Ginde AA, Mansbach JM, Camargo Jr. C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384-390.
4. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-119.
5. Stiles GW, Davis CL. Coccidioidal granuloma (coccidioidomycosis). J Amer Med Assoc 1942; 119: 765-769.
6. Bodnar LM, Simhan HN, Powers RW, et al. High prevalence of vitamin D insuffi ciency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007; 137: 447-452.
7. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
8. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D defi ciency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
9. Thompson GR 3rd. Pulmonary coccidioidomycosis. S emin Respir Crit Care Med 2011; 32: 754-763.
10. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001; 32: 708-715.
11. Bellamy R. Interferon-gamma and host susceptibility to tuberculosis. Am J Respir Crit Care Med 2003; 167: 946-947.
12. Bellamy R. Susceptibility to mycobacterial infections: The importance of host genetics. Genes Immun 2003; 4: 4-11.
13. Louie L, Ng S, Hajjeh R, et al. Infl uence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 1999; 5: 672-680.
14. Davies PD, Brown RC, Church HA, Woodhead JS. The effect of antituberculosis chemotherapy on vitamin D and calcium metabolism. Tubercle 1987; 68: 261-266.
15. Heidari A DJ, Jahangiri N, Ghafarizadeh N, Petersen G. Evaluation of vitamin D levels in patients with coccidioidomycosis, a case control study. In: Programs and Abstracts of the 49th Annual Infectious Diseases Society of America (IDSA) Meeting. Boston, MA: 2011: Poster # 947.
16. Rockett KA, Brookes R, Udalova I, et al. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66: 5314-5321.
17. Coussens A, Timms PM, Boucher BJ, et al. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009; 127: 539-548.
18. Segal GP, Lehrer RI, Selsted ME. I n vitro effect of phagocyte cationic peptides on Coccidioides immitis. J Infect Dis 1985; 151: 890-894.
19. Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37. J Immunol 2007; 178: 7190-7198.
20. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
21. Cox RA. Immunosuppression by cell wall antigens of C occidioides immitis. Rev Infect Dis 1988; 10 (Suppl. 2): S415-418.
22. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.